KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Restructuring Costs (2021 - 2025)

LifeMD filings provide 4 years of Restructuring Costs readings, the most recent being $27.8 million for Q4 2025.

  • On a quarterly basis, Restructuring Costs rose 269.0% to $27.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.3 million, a 153.2% increase, with the full-year FY2025 number at $32.0 million, up 16.08% from a year prior.
  • Restructuring Costs hit $27.8 million in Q4 2025 for LifeMD, up from $1.4 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $27.8 million in Q4 2025 to a low of $20896.0 in Q2 2021.
  • Median Restructuring Costs over the past 4 years was $4.4 million (2024), compared with a mean of $6.6 million.
  • The widest YoY moves for Restructuring Costs: up 431.68% in 2025, down 7.86% in 2025.
  • LifeMD's Restructuring Costs stood at $20896.0 in 2021, then soared by 118.51% to $45659.0 in 2022, then surged by 16386.31% to $7.5 million in 2024, then soared by 269.0% to $27.8 million in 2025.
  • The last three reported values for Restructuring Costs were $27.8 million (Q4 2025), $1.4 million (Q3 2025), and $10.9 million (Q2 2025) per Business Quant data.